[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao, Hong; Si, Chong-wen; Wei, Lai; Wan, Mo-bin; Ying, You-kuan; Hou, Jin-lin; Niu, Jun-qi

Zhao, Hong; Si, Chong-wen; Wei, Lai; Wan, Mo-bin; Ying, You-kuan; Hou, Jin-lin; Niu, Jun-qi.

Affiliation

Zhao H; First Hospital, Beijing University, Beijing 100034, China. minmin2001@126.com

Zhonghua Gan Zang Bing Za Zhi ; 14(5): 323-6, 2006 May.

Article in Zh | MEDLINE | ID: mdl-16732903

Subject(s)

Antiviral Agents/therapeutic use; Hepatitis B e Antigens/blood; Hepatitis B, Chronic/drug therapy; Interferon-alpha/therapeutic use; Adolescent; Adult; Aged; Antiviral Agents/adverse effects; Female; Hepatitis B, Chronic/immunology; Humans; Interferon alpha-2; Interferon-alpha/adverse effects; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Interferon-alpha / Hepatitis B, Chronic / Hepatitis B e Antigens Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2006 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links